Compare MDXG & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXG | GAU |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 530.2M | 606.0M |
| IPO Year | 2007 | 2006 |
| Metric | MDXG | GAU |
|---|---|---|
| Price | $3.67 | $2.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $9.00 | $4.08 |
| AVG Volume (30 Days) | 1.6M | ★ 2.4M |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $418,630,000.00 | N/A |
| Revenue This Year | N/A | $82.77 |
| Revenue Next Year | $13.02 | $29.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $3.03 | $1.22 |
| 52 Week High | $7.99 | $3.62 |
| Indicator | MDXG | GAU |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 41.66 |
| Support Level | $3.45 | $2.07 |
| Resistance Level | $7.39 | $2.74 |
| Average True Range (ATR) | 0.12 | 0.13 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 62.86 | 22.03 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.